Evidence map›Paper›PMID 31516428›Full record

ArticleTobacco induced diseases2018

Conflicts of interest in research on electronic cigarettes.

Cristina Martínez, Marcela Fu, Iñaki Galán, Mónica Pérez-Rios, Jose M Martínez-Sánchez, Maria J López, Xisca Sureda, Agustín Montes, Esteve Fernández

Abstract read
In one paragraph

Article in Tobacco induced diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cristina MartínezTobacco Control Unit, Cancer Control and Prevention Programme, Institut Català d'Oncologia-ICO, Barcelona, Spain.
Marcela FuTobacco Control Unit, Cancer Control and Prevention Programme, Institut Català d'Oncologia-ICO, Barcelona, Spain.
Iñaki GalánNational Centre for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain.
Mónica Pérez-RiosEpidemiology Unit, Galician Directorate for Public Health, Galician Health Authority, Santiago de Compostela, Spain.
Jose M Martínez-SánchezGroup of Evaluation of Health Determinants and Health Policies, Department of Medicine, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.
Maria J LópezConsortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Madrid, Spain.
Xisca SuredaSocial and Cardiovascular Epidemiology Research Group, School of Medicine, Universidad de Alcalá, Madrid, Spain.
Agustín MontesDepartment of Preventive Medicine and Public Health, School of Medicine, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
Esteve FernándezTobacco Control Unit, Cancer Control and Prevention Programme, Institut Català d'Oncologia-ICO, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe tobacco control community has raised some concerns about whether studies on electronic cigarettes (e-cigarettes) published in scientific journals hide conflicts of interest (COI) and whether such reports are biased. This study assessed potential COI in the e-cigarette scientific literature.

methodsCross-sectional study was conducted on e-cigarette publications indexed in PubMed up to August 2014. We extracted information about the authors (affiliations, location, etc.), publication characteristics (type, topic, subject, etc.), results and conclusions, presence of a COI statement, and funding by and/or financial ties to pharmaceutical, tobacco, and/or e-cigarette companies. An algorithm to determine the COI disclosure status was created based on the information in the publication. Prevalence ratios (PRs) and confidence intervals (CIs) were calculated to identify associations with COI disclosure, controlling for several independent variables.

resultsOf the 404 publications included in the analysis, 37.1% (n=150) had no COI disclosure statement, 38.6% declared no COI, 13.4% declared potential COI with pharmaceutical companies, 3.0% with tobacco companies, and 10.6% with e-cigarette companies. The conclusions in publications with COI, which were mainly tied to pharmaceutical companies, were more likely to be favourable to e-cigarette use (PR=2.23; 95% CI: 1.43-3.46). Publications that supported the use of e-cigarettes for both harm reduction (PR=1.81; 95%CI: 1.14-2.89) and smoking cessation (PR=2.02; 95% CI: 1.26-3.23) were more likely to have conclusions that were favourable to e-cigarettes.

conclusionsOne-third of the publications reporting studies on e-cigarettes did not have a COI disclosure statement, and this proportion was even higher in news articles, editorials and other types of publications. Papers with conclusions that were favourable to e-cigarette use were more likely to have COI. Journal editors and reviewers should consider evaluating publications, including funding sources, to determine whether the results and conclusions may be biased.

Indexed as

bibliography as topicconflicts of interestelectronic cigarettes

Identifiers

PMID31516428
PMCPMC6659563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.